OrganoReady: Turnkey Organoid and Organ-on-a-Chip Solutions

Explore ready-to-use Organ-on-a-Chip screening designed to overcome key barriers to adoption in this webinar hosted live on April 8, 2026.

Key topics:

Perfused colon organoids on OrganoPlate® for high throughput drug screening & functional assays

Assessing barrier integrity, gut toxicity & transport

Vascularized models for inflammation & immune migration

Seamless integration into automation workflows

Advanced in vitro models such as organoids and organ-on-a-chip systems offer more human-relevant microphysiological platforms for drug discovery, but high-throughput screening (HTS) adoption has often been limited by complex workflows, specialized expertise, and engineering constraints. Ready-to-use platforms are helping overcome these barriers by making advanced tissue models more accessible for routine research and screening.

In this webinar, Dr. Paul Vulto introduces OrganoReady®, a ready-to-use organoid platform designed to simplify adoption of advanced in vitro models. He demonstrates how pre-seeded, perfused stem cell-derived colon organoids and vascular models can support drug screening, trans-epithelial barrier integrity, automated drug transport, GI toxicity profiling, and inflammation studies while integrating seamlessly into existing laboratory workflows. Through real-world examples, he highlights how these scalable, human-relevant models enable reproducible preclinical research without requiring specialized organoid expertise.

Key Topics:

Overcoming barriers to adopting organoid and organ-on-a-chip technologies
Using perfused colon organoids for drug transport, barrier function, and toxicity studies
Applications of vascular models for inflammation and immune cell migration
High-throughput screening with scalable, human-relevant tissue models
Integrating advanced organoid models into existing drug discovery workflows

Speaker Biography

Paul Vulto, PhD
Co-CEO and co-founder, MIMETAS

Paul is co-CEO and co-founder of MIMETAS, an early pioneer in commercial Organ-on-a-Chip solutions. The high throughput OrganoPlate® platform, launched in 2014, was the first commercially available Organ-on-a-Chip platform and was based on Paul’s invention of PhaseGuide technology. Since then, Paul and his team have been pushing the boundaries of in vitro modeling and assaying, including tissue vascularization, high throughput screening, and productization of cell biology. Prior to founding MIMETAS, Paul worked at the Universities of Leiden, Freiburg, and Bologna and start-up companies Silicon Biosystems and ScienceWorks. In 2023 Paul was named a fellow to the Netherlands Academy of Engineering.

Publish Date: September 21, 2026

See other videos & webinars

Webinar: OrganoReady: Turnkey Organoid and Organ-on-a-Chip Solutions

Explore ready-to-use Organ-on-a-Chip screening designed to overcome key barriers to adoption in this webinar hosted live on April 8, 2026.

Key topics:

Perfused colon organoids on OrganoPlate® for high throughput drug screening & functional assays
Assessing barrier integrity, gut toxicity & transport
Vascularized models for inflammation & immune migration
Seamless integration into automation workflows

To view the webinar, please complete the form, or sign in to your account.

I agree to receive future electronic communications from STEMCELL. I acknowledge that I can unsubscribe at any time.

By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.

Request Pricing

Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):

Estimated delivery time for your area

Product sample or exclusive offer

In-lab demonstration